HumanZyme

HumanZyme is a privately held biotechnology company located in Chicago, Illinois. With 12 employees, HumanZyme focuses on manufacturing recombinant human proteins for research and therapeutic applications. The company specializes in producing authentic recombinant human cytokines and growth factors, leveraging its HEK293 expression platform. This platform enables cost-effective and scalable production of proteins, catering to the needs of both small and large-scale projects. Their proteins are specifically designed for stem cell research and drug discovery. HumanZyme prioritizes quality by producing proteins in chemically defined, animal product, and Xeno-free media, ensuring accurate folding, glycosylation, disulfide links, and subunit assembly, ultimately resulting in increased activity and stability. HumanZyme distinguishes itself through the use of authentic human proteins. These proteins closely resemble naturally occurring counterparts, potentially leading to enhanced effectiveness and compatibility with biological systems. To learn more about HumanZyme's offerings, please visit their website at humanzyme.com.